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The presence of peripheral arterial occlusive disease increases the morbidity and mortality of patients with coronary artery
disease. The objective of the present study was to calculate the prevalence of peripheral arterial occlusive disease in patients
referred for coronary angiography. This prevalence study was carried out at the Hemodynamics Unit of Hospital Santa Isabel,
Salvador, Brazil, from December 2004 to April 2005. After approval by the Ethics Committee of the hospital, 397 patients with
angiographic signs of coronary artery disease were enrolled. Diagnosis of peripheral arterial occlusive disease was made using
the ankle-brachial blood pressure index (≤0.90). Statistical analyses were performed using the z test and a level of significance
of α = 5%, 95%CI, the chi-square test and t-test, and multiple logistic regression analysis. The prevalence of peripheral arterial
occlusive disease was 34.3% (95%CI: 29.4-38.9). Mean age was 65.7 ± 9.4 years for patients with peripheral arterial occlusive
disease, and 60.3 ± 9.8 years for patients without peripheral arterial occlusive disease (P = 0.0000003). The prevalence of
peripheral arterial occlusive disease was 1.57 times greater in patients with hypertension (P = 0.007) and 2.91 times greater in
patients with coronary stenosis ≥50% (P = 0.002). Illiterate patients and those with little education had a 44% higher chance of
presenting peripheral arterial occlusive disease probably as a result of public health prevention policies of limited effectiveness.
The prevalence of peripheral arterial occlusive disease in patients referred to a tertiary care hospital in Salvador, Bahia, for
coronary angiography, was 34.3%.
Key words: Peripheral vascular diseases; Coronary atherosclerosis; Prevalence; Epidemiology; Ultrasound; Coronary
angiography
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Introduction
Peripheral arterial occlusive disease (PAOD) in pa-
tients with coronary artery disease (CAD) compromises
the recovery and postoperative quality of life of patients
who undergo myocardial revascularization (1,2).
Early identification of PAOD by vascular surgeons in
patients with CAD is fundamental to reduce morbidity and
mortality in this group of patients (1,3-7).
Studies involving patients with CAD and PAOD have
detected greater morbidity and mortality than among pa-
tients with only CAD. Patients with CAD and PAOD had a
greater risk of cerebral vascular accidents after myocardial
revascularization and a 25% increase in mortality (4,6,8,9).
Although several investigators have reported the ef-
fects of PAOD on the survival of patients with CAD, few
studies in the literature have estimated the prevalence of
PAOD in patients with CAD using the ankle-brachial blood
pressure index (ABPI) (10). The ethnic diversity and mis-
cegenation of the Brazilian population require that epide-
miological studies use high-quality diagnostic methods
and include representative samples of the population to
define the rate of high-risk patients and to promote early
follow-up by vascular surgeons to prevent complications.
The objective of the present study was to estimate the
prevalence of PAOD in patients referred for coronary an-
giography and presenting CAD. The prevalence of PAOD
was also evaluated according to the severity of CAD, and
the clinical, epidemiological and demographic characteris-
tics of the sample were described.
Material and Methods
This prevalence study was conducted at the Hemody-
namics Unit of Hospital Santa Izabel, Salvador, BA, Brazil.
After approval by the Ethics Committee of the hospital,
patients consecutively seen in this unit were enrolled from
December 2004 to April 2005 during the three weekly
material collection shifts. Patients were referred for an-
giography by the assistant physician based on clinical
criteria, effort test or myocardial scintigraphy results. The
authors of the study did not participate in angiography. The
sample was selected sequentially at the Hemodynamics
Unit. All patients included in the study signed an informed
consent form.
A vascular surgeon on the study team conducted physi-
cal vascular examinations before coronary angiography
during routine medical examination at the Hemodynamics
Unit. PAOD was diagnosed by measurement of ABPI
using a Medmega DV610 unit (Medmega Indústria de
Equipamentos Médicos Ltda., Franca, SP, Brazil) for Dop-
pler sonography. Patients were examined while lying down
in a room at 25°C after resting for 30 min. Systolic blood
pressure was measured with a mercury sphygmomanom-
eter placed at the level of the patient; the cuff was inflated
to 10 mmHg above the patient’s systolic pressure and
deflated at 2 mmHg/s. Systolic pressure was measured in
both arms and in the dorsal arteries of the foot and poste-
rior tibial arteries of each lower extremity. To determine
ABPI, the greatest pressures found in the dorsal artery of
the foot or posterior tibial artery of the right and left lower
extremities were divided by the greatest pressure found for
the right or left arm (11,12). When this index was lower
than or equal to 0.90, the patient was diagnosed as having
PAOD (13,14). The values obtained by the two examiners
for the first 30 measurements had good reproducibility,
with a general agreement coefficient of 96% and kappa of
0.78 (15).
After coronary angiography was performed, only the
patients with a diagnosis of CAD provided by the Hemody-
namics Unit were included in the study. Severity of CAD
was established by the hemodynamics specialist of the
Unit. Stenosis that affected less than 50% of the coronary
artery lumen was classified as wall abnormalities, and
stenosis that affected 50% or more of the lumen was
classified as one-, two- or three-vessel disease according
to the number of coronary arteries compromised (16).
Patients without atherosclerotic coronary artery alterations
were excluded from the study.
Sample size was calculated to obtain the minimum
number of individuals necessary to estimate prevalence
(17), assuming a PAOD prevalence of 30%, a 95% confi-
dence level, precision of 5%, and a design effect of 1.1,
and the result was a sample size of about 387 patients.
The z test was used for statistical analysis at a 95%
confidence interval (95%CI) and a level of significance of α
= 5%. The chi-square test was used to analyze the inde-
pendence between variables, and the t-test to compare
means. Multiple logistic regression analysis was used in
multivariate analysis (18). Patients were described ac-
cording to usual descriptive statistics (17,19).
Hypertension, dyslipidemia, smoking, and diabetes
mellitus were defined as clinical and epidemiological vari-
ables and classified as follows: hypertension: mild - con-
trolled with 1 drug; moderate - controlled with 2 drugs;
severe - controlled with ≥3 drugs or not controlled; diabe-
tes mellitus: mild - type II, controlled with diet or an oral
hypoglycemic agent; moderate - type II controlled with
insulin; severe - type I, juvenile diabetes; smoking: mild -
smoked in the last 10 years; moderate - smoked <1 pack/
day or quit <1 year before; severe - smoked ≥1 pack/day;
dyslipidemia: mild - easily controlled with diet; moderate -
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controlled with a strict diet; severe - controlled with diet and
medication (20). Origin, sex, education, occupation, and
marital status were defined as demographic variables.
Education was classified as illiterate, primary (up to 4
years of primary education), secondary (up to third year of
secondary education) or tertiary (higher education with or
without graduate degrees).
Results
A total of 397 patients were examined. Mean age was
62 ± 10 years (range: 43 to 87 years). The prevalence of
PAOD in patients referred for coronary angiography and
presenting CAD was 34.3% (136/397; 95%CI: 29.4-38.9).
Mean age was 65.8 ± 9.4 years for patients with PAOD and
60.3 ± 10 years for patients without PAOD. The difference
between mean ages was statistically significant (P =
0.0000002; t-test).
Table 1 shows the demographic characteristics of the
sample: 54.9% (218/397) of the patients were from Salva-
dor, the state capital city; 59.4% (236/397) were illiterate or
had primary education; 63.2% (251/397) were not retired,
and 69.8% (277/397) were married. Of the patients with
PAOD, 72.1% (98/136) were illiterate or had primary edu-
cation, and 54.4% (74/136) were not retired.
The clinical and epidemiological characteristics of the
sample are shown in Table 2: 34.3% (136/397) had smoked
in the past 10 years; 26.2% (104/397) had diabetes; 70.0%
(278/397) had hypertension, and 60.3% (239/397) had
dyslipidemia. Of the patients with PAOD, 14.7% were
heavy smokers and 40.4% had severe dyslipidemia.
The analysis of the association of clinical and epide-
miological variables with PAOD showed that patients with
hypertension had a statistically greater prevalence of the
disease than patients without hypertension. The preva-
lence ratio for this association was 1.57 (95%CI: 1.11-
2.24; P = 0.007; chi-square test), which indicates that the
prevalence of PAOD was 1.57 times greater in patients
with hypertension. The associations with the other vari-
ables were not statistically significant (Table 3).
Table 4 shows the frequency of each type of coronary
lesion. Of the 397 patients in the sample, 88.2% (350) had
≥50% stenosis in at least one coronary artery, and 40.2%
of patients with PAOD had two-vessel disease.
Table 5 shows the separate comparisons between
each type of coronary lesion and other lesions. Patients
with one-, two- or three-vessel disease had a statistically
greater prevalence of PAOD than patients with wall abnor-
malities. Similarly, when patients with one-, two- or three-
vessel disease were compared as a single group, their
prevalence of PAOD was statistically greater than among
Table 1. Distribution of demographic variables in the overall
sample and in patients with peripheral arterial occlusive disease
(PAOD).
Variable Overall sample With PAOD
Sex
Male 249 (62.7%) 77 (56.6%)
Female 148 (37.3%) 59 (43.4%)
Origin
Capital city 218 (54.9%) 77 (56.6%)
Other cities 179 (45.1%) 59 (43.4%)
Education
Illiterate 37 (9.3%) 16 (11.8%)
Primary 199 (50.1%) 82 (60.3%)
Secondary 110 (27.7%) 27 (19.8%)
Tertiary 51 (12.9%) 11 (8.0%)
Occupation
Not retired 251 (63.2%) 74 (54.4%)
Retired 146 (36.8%) 62 (45.6%)
Marital status
Married 277 (69.8%) 91 (66.9%)
Widowed 58 (14.6%) 26 (19.1%)
Single 44 (11.1%) 13 (9.6%)
Separated/divorced 18 (4.5%) 6 (4.4%)
Data are reported as number with percent in parentheses.
Table 2. Distribution of clinical and epidemiologic variables in the
overall sample and in patients with peripheral arterial occlusive
disease (PAOD).
Variable Overall sample With PAOD
Smoking
Severe 46 (11.6%) 20 (14.7%)
Moderate 28 (7.1%) 9 (6.6%)
Mild 62 (15.6%) 20 (14.7%)
No smoking 261 (65.7%) 87 (64.0%)
Diabetes mellitus
Severe 0 (0%) 0 (0%)
Moderate 23 (5.8%) 12 (8.8%)
Mild 81 (20.4%) 29 (21.3%)
No diabetes 293 (73.8%) 95 (69.9%)
Hypertension
Severe 56 (14.1%) 15 (11.1%)
Moderate 104 (26.2%) 49 (36.0%)
Mild 118 (29.7%) 43 (31.6%)
No hypertension 119 (30.0%) 29 (21.3%)
Dyslipidemia
Severe 152 (38.3%) 55 (40.4%)
Moderate 30 (7.6%) 8 (5.9%)
Mild 57 (14.4%) 25 (18.4%)
No dyslipidemia 158 (39.8%) 48 (35.3%)
Data are reported as number with percent in parentheses.
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patients with wall abnormalities.
Mean ABPI was 0.94 ± 0.21. Mean ABPI for patients
with diabetes was 0.93 ± 0.22, but the difference was not
statistically significant when compared with the mean value
of 0.94 ± 0.19 for patients without diabetes.
Table 6 presents the results of multivariate analysis.
The clinical/epidemiological and social/demographic vari-
ables considered in the study were as follows: angiogra-
phy result (one-, two-, or three-vessel disease versus
parietal irregularities), interaction term between hyperten-
sion and angiography result, education (illiterate and little
schooling versus others), age (years), interaction term
between age and dyslipidemia, dyslipidemia (yes versus
no), and hypertension (yes versus no). This analysis ob-
tained an adequate power (97%) to investigate the vari-
able education level only. Illiterate patients and those with
little education showed a 44% higher chance of presenting
PAOD.
Patients also underwent a physical vascular examina-
tion. Results showed that 4.5% (18/397) had carotid bruit,
1.7% (7/397) had decreased pulse and blood pressure in
the upper extremities, and 43.8% (174/397) had reduced
or no pulse in at least one of the posterior tibial arteries or
dorsal arteries of the foot in the lower extremities. No
abnormalities were found in thorax or abdomen.
Discussion
The prevalence of PAOD in patients with CAD ranges
from 5 to 40% (5,10,21-26). Such broad range may be
justified by the fact that prevalence studies enroll different
populations, are not randomized, investigate few clinical
presentations of coronary disease, and use different diag-
nostic methods. Most studies that used ABPI enrolled
small samples, sometimes only hospitalized patients who
probably had more severe CAD. Therefore, comparisons
with results of studies that selected large and diversified
samples of patients with CAD are difficult (10,19).
The measurement of ABPI is a widely accepted meth-
od for epidemiological studies (13,14). However, results
vary according to the time when patients are examined and
who performs the measurements (27). This index also
shows a greater number of false-negative results among
patients with diabetes because of the calcification of artery
walls. It is estimated that 5 to 10% of patients with diabetes
have an artificial elevation of blood pressure due to the
incompressibility of vessels, and that blood pressure dif-
ferences between patients with and without diabetes is
about 25 mmHg (28). One alternative to reduce the num-
ber of false-negative results is to use toe blood pressure
measurements (13,14), but this method is not widely ac-
Table 4. Severity of coronary artery disease (CAD) in the overall
sample and in patients with peripheral arterial occlusive disease
(PAOD).
Severity Overall sample With PAOD
Three-vessel CAD 139 (35.0%) 52 (37.4%)
Two-vessel CAD 102 (25.7%) 41 (40.2%)
One-vessel CAD 109 (27.5%) 37 (33.9%)
Wall abnormalities 47 (11.8%) 6 (12.8%)
Data are reported as number with percent in parentheses.
Table 3. Association of clinical and epidemiologic variables with
peripheral arterial occlusive disease (PAOD) in 397 patients.




Yes 49 (36.0%) 87 (64.0%) 1.08 0.82—1.43
No 87 (33.3%) 174 (66.7%)
Diabetes mellitus
Yes 41 (39.4%) 63 (60.6%) 1.22 0.91—1.62
No 95 (32.4%) 198 (67.6%)
Hypertension
Yes 107 (38.5%) 171 (61.5%) 1.57 1.11—2.24*
No 29 (24.4%) 90 (75.6%)
Dyslipidemia
Yes 88 (36.8%) 151 (63.2%) 1.21 0.91—1.62
No 48 (30.4%) 110 (69.6%)
Data are reported as number with percent in parentheses, preva-
lence ratio or 95%CI (95% confidence interval).
*Statistically significant (Taylor series method).
Table 5. Association between severity of coronary artery dis-
ease and peripheral arterial occlusive disease.
Comparisons PR 95%CI χ2 P
3V x WA 2.93 1.35-6.38 8.83 0.003*
3V x 1V 1.10 0.79-1.55 0.19 0.666
3V x 2V 0.93 0.68-1.28 0.09 0.760
2V x WA 3.15 1.40-6.90 9.98 0.002*
2V x 1V 1.18 0.83-1.69 0.64 0.425
1V x WA 2.66 1.20-5.78 6.35 0.012*
3V, 2V, and 1V x WA 2.91 1.36-6.22 9.88 0.002*
1V = one-vessel disease; 2V = two-vessel disease; 3V = three-
vessel disease; WA = wall abnormalities; PR = prevalence ratio;
95%CI = 95% confidence interval; χ2 = chi-square test.
*P < 0.05 (Taylor series method and chi-square test).
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cepted because of its low sensitivity (29). False-negative
results in patients with diabetes may not have significant-
ly affected the results of the present study because the
difference in mean ABPI between patients with and with-
out diabetes was not statistically significant. Studies that
use color Doppler sonography to investigate PAOD in
patients with CAD are not easily compared with our study
because their measurement criteria are the visualization
of an atherosclerotic plaque and the measurement of
stenosis (1,3,30-33). The ABPI has been shown to corre-
late with clinical involvement and hemodynamic reper-
cussions of stenosis in the peripheral artery system of
the lower extremities (34).
In our study, PAOD was more prevalent among pa-
tients with two-vessel disease and was associated with
≥50% stenosis. Other studies also found a higher fre-
quency of PAOD in patients with more severe CAD (21.3
to 25%), but did not evaluate the statistical significance of
their results (5,10). This information provides scientific
evidence to support early vascular screening of patients
with CAD who are at a greater risk of having PAOD.
The description of the demographic characteristics of
patients in this prevalence study is important because
little education and a low socioeconomic status have
been described as important risk factors for cardiovascu-
lar diseases (35,36). Moreover, PAOD has been found to
be associated with geographical location and population
under study (13,14). Most studies about the prevalence
of PAOD in patients with CAD were conducted in devel-
oped countries, whose population profiles and public
health policies reflect their socioeconomic reality. The
description of demographic characteristics of patients
with PAOD in our study showed that most patients worked,
had a family, and had little education. Therefore, the poor
control of this disease and the lack of specialized follow-
up of these patients may represent a high socioeconomic
cost for developing countries (37,38). Moreover, many
patients in our study came from other cities in the State of
Bahia, which may suggest little decentralization of the health
system. The great patient demand that results from such
centralization may impair the provision of adequate health
care (37).
In the present study, the frequency of risk factors for
atherosclerotic disease was high and similar to that found in
other studies (31,39,40). Possible explanations for the broad
variation in the prevalence of these risk factors among
different ethnic groups are economic and sociocultural fac-
tors, which may be responsible for the high frequency of
cardiovascular disease in developing countries (35). The
cardiovascular risk profile of the population was critical in the
city where this study was conducted, which has more than
2,500,000 inhabitants, 70% of whom have mixed ethnic
backgrounds, and most have little education and a low
income. Improvements in educational levels and socioeco-
nomic status may decrease the high frequency of risk factors
(39).
This study was designed to estimate the prevalence of
PAOD in the lower extremities of patients referred for coro-
nary angiography and presenting CAD, and, therefore, the
results of the physical examination of other segments can-
not be statistically interpreted. However, abnormalities found
in the upper extremities and carotid arteries support the
findings of studies that have emphasized the importance of
broad diagnostic screening examinations in patients with
atherosclerotic disease because of the possible simulta-
neous involvement of several organs (7).
To sum up, the prevalence of PAOD in patients referred
for coronary angiography and presenting CAD in the present
study was 34.3%, and was associated with illiteracy or little
education, older age, hypertension, and coronary stenosis
≥50%. Such a high prevalence rate stresses the need for
early and routine evaluation of patients with CAD by vascu-
lar surgeons to prevent the severe complications of associ-
ated PAOD.
Table 6. Association between prevalence of peripheral arterial occlusive disease and clinical/epidemiological and
social/demographic variables: results of the logistic regression model.
Variable ß SEß P Odds ratio  95%CI
Coronary angiography result 0.61 0.24 0.005 1.83 1.32—2.54
Interaction term between hypertension and coronary 0.39 0.24 0.112 1.47 1.06—2.04
angiography result
Education 0.37 0.12 0.002 1.44 1.22—1.70
Age 0.05 0.01 0.000 1.05 1.03—1.07
Interaction term between age and dyslipidemia 0.02 0.01 0.079 1.02 1.01—1.04
Dyslipidemia -1.24 0.82 0.134 0.29 0.09—0.90
Hypertension -0.07 0.20 0.766 0.93 0.67—1.29
SEß = standard error of beta; 95%CI = 95% confidence interval.
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